Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
Clinical trial NCT03450057 · COMPLETED
Trial details
- NCT number
- NCT03450057
- Sponsor
- Hellenic Society of Hematology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-15
- Primary completion
- 2021-03-22
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.